BG63329B1 - Лекарствени форми, съдържащи ибупрофен и кодеин - Google Patents

Лекарствени форми, съдържащи ибупрофен и кодеин Download PDF

Info

Publication number
BG63329B1
BG63329B1 BG101252A BG10125297A BG63329B1 BG 63329 B1 BG63329 B1 BG 63329B1 BG 101252 A BG101252 A BG 101252A BG 10125297 A BG10125297 A BG 10125297A BG 63329 B1 BG63329 B1 BG 63329B1
Authority
BG
Bulgaria
Prior art keywords
dosage form
form according
codeine
ibuprofen
mixtures
Prior art date
Application number
BG101252A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG101252A (en
Inventor
Brian Holmes
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9417041A external-priority patent/GB9417041D0/en
Priority claimed from GB9419921A external-priority patent/GB9419921D0/en
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of BG101252A publication Critical patent/BG101252A/xx
Publication of BG63329B1 publication Critical patent/BG63329B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BG101252A 1994-08-23 1997-02-21 Лекарствени форми, съдържащи ибупрофен и кодеин BG63329B1 (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9417041A GB9417041D0 (en) 1994-08-23 1994-08-23 Improved formulations
GB9419921A GB9419921D0 (en) 1994-10-04 1994-10-04 Improved formulations
PCT/GB1995/001947 WO1996005834A1 (en) 1994-08-23 1995-08-16 Improved pharmaceutical formulations containing ibuprofen and codeine

Publications (2)

Publication Number Publication Date
BG101252A BG101252A (en) 1998-02-27
BG63329B1 true BG63329B1 (bg) 2001-10-31

Family

ID=26305507

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101252A BG63329B1 (bg) 1994-08-23 1997-02-21 Лекарствени форми, съдържащи ибупрофен и кодеин

Country Status (24)

Country Link
EP (1) EP0777477B1 (cs)
JP (1) JP3874793B2 (cs)
KR (1) KR100397082B1 (cs)
CN (1) CN1083265C (cs)
AT (1) ATE227574T1 (cs)
AU (1) AU699224B2 (cs)
BG (1) BG63329B1 (cs)
BR (1) BR9508760A (cs)
CA (1) CA2156768A1 (cs)
CZ (1) CZ287558B6 (cs)
DE (1) DE69528838T2 (cs)
DK (1) DK0777477T3 (cs)
ES (1) ES2187566T3 (cs)
HU (1) HU227759B1 (cs)
MX (1) MX9701390A (cs)
NO (1) NO322200B1 (cs)
NZ (1) NZ291223A (cs)
PL (1) PL181215B1 (cs)
PT (1) PT777477E (cs)
RU (1) RU2140782C1 (cs)
SK (1) SK282183B6 (cs)
TW (1) TW493984B (cs)
UA (1) UA42781C2 (cs)
WO (1) WO1996005834A1 (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608073B1 (en) 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
JP2001253826A (ja) * 2000-03-09 2001-09-18 Maruzen Pharmaceut Co Ltd 内服用剤
US7183410B2 (en) 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
US20040253311A1 (en) * 2002-12-18 2004-12-16 Roger Berlin Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
PL1912650T3 (pl) 2005-08-03 2018-01-31 Sprout Pharmaceuticals Inc Zastosowanie flibanseryny w leczeniu otyłości
WO2007048803A1 (en) 2005-10-29 2007-05-03 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
WO2007069033A2 (en) * 2005-12-12 2007-06-21 Adcock Ingram Limited Pharmaceutical compositions comprising dexibuprofen, an opiate analgesic and paracetamol
US20090312242A1 (en) 2006-06-30 2009-12-17 Ramiro Castro Flibanserin for the treatment of urinary incontinence and related diseases
WO2008007426A1 (fr) * 2006-07-12 2008-01-17 Aska Pharmaceutical Co., Ltd. Agent analgésique
WO2008019996A2 (en) 2006-08-14 2008-02-21 Boehringer Ingelheim International Gmbh Formulations of flibanserin and method for manufacturing the same
KR20090045945A (ko) 2006-08-25 2009-05-08 베링거 인겔하임 인터내셔날 게엠베하 제어 방출 시스템 및 이의 제조방법
KR20090065513A (ko) * 2006-10-05 2009-06-22 코와 가부시키가이샤 이부프로펜 및 트라넥삼산을 함유하는 고형 제제
PE20091188A1 (es) 2007-09-12 2009-08-31 Boehringer Ingelheim Int Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen
PT2279731E (pt) * 2008-04-23 2013-08-30 Farmasierra Mfg S L Composição farmacêutica melhorada contendo ibuprofeno e codeína
ES2365961B1 (es) * 2010-03-30 2013-01-24 Farmasierra Manufacturing S.L. Formulación farmacéutica a base de ibuprofeno y codeína de estabilidad mejorada.
KR101317809B1 (ko) * 2011-06-07 2013-10-16 한미약품 주식회사 암세포의 성장을 억제하는 아마이드 유도체 및 비금속염 활택제를 포함하는 약학 조성물
KR20140096571A (ko) 2013-01-28 2014-08-06 한미약품 주식회사 1-(4-(4-(3,4-디클로로-2-플루오로페닐아미노)-7-메톡시퀴나졸린-6-일옥시)피페리딘-1-일)프로프-2-엔-1-온의 제조방법
HUE060712T2 (hu) 2014-08-28 2023-04-28 Sanofi Aventis Deutschland Filmborított tabletta akut fájdalom kezelésére
CN105395508B (zh) * 2015-12-14 2018-06-29 西南药业股份有限公司 一种洛芬待因复方制剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4571400A (en) * 1984-12-18 1986-02-18 Belleview Pharmaceutical, Inc. Dihydrocodeine/ibuprofen pharmaceutical compositions and method
GB8905815D0 (en) * 1989-03-14 1989-04-26 Beecham Group Plc Medicament
GB9121204D0 (en) * 1991-10-04 1991-11-20 Euro Celtique Sa Medicament

Also Published As

Publication number Publication date
CZ287558B6 (en) 2000-12-13
DK0777477T3 (da) 2003-03-17
PL318807A1 (en) 1997-07-07
RU2140782C1 (ru) 1999-11-10
AU3228995A (en) 1996-03-14
SK23697A3 (en) 1997-08-06
CZ54697A3 (en) 1997-12-17
CN1159754A (zh) 1997-09-17
NO970782D0 (no) 1997-02-20
SK282183B6 (sk) 2001-11-06
CA2156768A1 (en) 1996-02-24
UA42781C2 (uk) 2001-11-15
BR9508760A (pt) 1998-01-13
CN1083265C (zh) 2002-04-24
KR970705389A (ko) 1997-10-09
ATE227574T1 (de) 2002-11-15
TW493984B (en) 2002-07-11
AU699224B2 (en) 1998-11-26
BG101252A (en) 1998-02-27
KR100397082B1 (ko) 2004-02-11
PT777477E (pt) 2003-03-31
NO970782L (no) 1997-02-20
MX9701390A (es) 1998-06-30
HU227759B1 (en) 2012-02-28
EP0777477B1 (en) 2002-11-13
JPH10504557A (ja) 1998-05-06
WO1996005834A1 (en) 1996-02-29
ES2187566T3 (es) 2003-06-16
EP0777477A1 (en) 1997-06-11
NO322200B1 (no) 2006-08-28
HUT77385A (hu) 1998-04-28
JP3874793B2 (ja) 2007-01-31
NZ291223A (en) 1998-12-23
DE69528838T2 (de) 2003-07-10
PL181215B1 (pl) 2001-06-29
DE69528838D1 (de) 2002-12-19

Similar Documents

Publication Publication Date Title
BG63329B1 (bg) Лекарствени форми, съдържащи ибупрофен и кодеин
AU695865B2 (en) Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound
HRP20030527A2 (en) Pharmaceutical compositions comprising amlodipinemaleate
US4888343A (en) Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process
EP0749308A1 (en) Film coated tablet of paracetamol and domperidone
IL106743A (en) Tablets with enhanced bioavailability of claudonic acid
ZA200309172B (en) Swallow tablet comprising paracetamol.
JPH05246845A (ja) イブプロフェン含有解熱鎮痛剤
JPH0141608B2 (cs)
SK284728B6 (sk) Farmaceutický prostriedok obsahujúci ibuprofen a domperidone na ošetrovanie migrény
JPS61268624A (ja) 抗高血圧症および心臓保護作用を有する医薬調剤
JP2014012660A (ja) ロキソプロフェン含有医薬組成物
JP2016106129A (ja) ロキソプロフェンナトリウムとビタミンｂ１を含有する固形製剤２
JP2009007295A (ja) イブプロフェンの昇華が抑制された固形製剤
EP0975337B1 (en) Fast release compressed tablet of flurbiprofen
JP2013151565A (ja) イブプロフェンの昇華が抑制された固形製剤
JP2019137651A (ja) 医薬組成物
JPS6360926A (ja) 感冒薬